Liver Diseases  >>  Tarvacin (bavituximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tarvacin (bavituximab) / OncXerna Therap
NCT01273948: Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection

Completed
2
66
RoW
Bavituximab, Bavituxmab, Pegylated interferon (PEG-IFN), Pegasys
Peregrine Pharmaceuticals
Hepatitis C
01/12
02/12

Download Options